|
| Exchange Disseminated Time 01/02/2017 13:04:38 | Amrutanjan Health Care Ltd has informed BSE that a meeting of the Board of Directors is scheduled to be held on February 09, 2017, inter alia, to consider and approve the following:
1. Un-audited Standalone Financial Results along with the Limited Review Report for the quarter and nine months ended December 31, 2016.
2. Declaration of 2nd interim dividend for the financial year 2016-17
In view of the above, as per the SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company's Code of Conduct to regulate, monitor and report trading by insiders, the trading window for dealing in the securities of the Company shall remain closed for the Specified Persons (Directors & Designated Employees) from February 02, 2017 to February 12, 2017 (both days inclusive). |
|
|